연구성과로 돌아가기
JCR 2022 저널 목록 (891 / 2070)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Terminology | JOHN BENJAMINS PUBLISHING CO | 0929-9971 | 1569-9994 | SSCI | LINGUISTICS | 266 | 0.8 | Q3 | 64.7 | 35.3 | 126/194 | 1.5 | Q3 | 0.8 | 1.0 | 0.47 | 193/289 | Q3 | 33.39 | 0.000 | 0.047 | 0.460 | Q3 | 7 | 100.0% | 10.1 | 10.9 | 7 | 12.9% | 2025-04-21 10:08:26 | 바로가기 |
| Archives of Iranian Medicine | ACAD MEDICAL SCIENCES I R IRAN | 1029-2977 | 1735-3947 | SCIE | MEDICINE, GENERAL & INTERNAL | 2,674 | 2.1 | Q3 | 64.8 | 35.2 | 110/169 | 1.9 | Q3 | 2.1 | 0.2 | 0.42 | 123/327 | Q2 | 62.54 | 0.002 | 0.480 | 0.425 | Q3 | 89 | 87.6% | 6.9 | 8.6 | 78 | 89.4% | 2025-04-21 10:15:50 | 바로가기 |
| DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | ELSEVIER SCIENCE INC | 0732-8893 | 1879-0070 | SCIE | MICROBIOLOGY | 7,386 | 2.9 | Q3 | 64.8 | 35.2 | 88/135 | 2.5 | Q4 | 2.8 | 0.8 | 0.62 | 81/156 | Q3 | 48.40 | 0.006 | 1.403 | 0.663 | Q3 | 156 | 97.4% | 8.0 | 4.4 | 152 | 20.9% | 2025-04-21 10:17:19 | 바로가기 |
| EUROPEAN JOURNAL OF PROTISTOLOGY | ELSEVIER GMBH | 0932-4739 | 1618-0429 | SCIE | MICROBIOLOGY | 1,832 | 2.9 | Q3 | 64.8 | 35.2 | 88/135 | 2.4 | Q4 | 2.3 | 0.7 | 0.69 | 68/156 | Q2 | 56.73 | 0.001 | 0.239 | 0.429 | Q4 | 57 | 94.7% | 8.1 | 15.7 | 54 | 10.5% | 2025-04-21 10:17:25 | 바로가기 |
| EXTREMOPHILES | SPRINGER JAPAN KK | 1431-0651 | 1433-4909 | SCIE | MICROBIOLOGY | 3,478 | 2.9 | Q3 | 64.8 | 35.2 | 88/135 | 2.6 | Q4 | 2.7 | 1.0 | 0.52 | 104/156 | Q3 | 33.65 | 0.002 | 0.339 | 0.495 | Q3 | 37 | 89.2% | 9.8 | 9.4 | 33 | 17.8% | 2025-04-21 10:17:22 | 바로가기 |
| INTERNAL MEDICINE JOURNAL | WILEY | 1444-0903 | 1445-5994 | SCIE | MEDICINE, GENERAL & INTERNAL | 5,311 | 2.1 | Q3 | 64.8 | 35.2 | 110/169 | 2.1 | Q3 | 2.0 | 0.7 | 0.49 | 109/327 | Q2 | 66.82 | 0.006 | 1.362 | 0.633 | Q2 | 410 | 92.2% | 6.0 | 7.0 | 378 | 8.9% | 2025-04-21 10:15:45 | 바로가기 |
| IRISH JOURNAL OF MEDICAL SCIENCE | SPRINGER LONDON LTD | 0021-1265 | 1863-4362 | SCIE | MEDICINE, GENERAL & INTERNAL | 3,420 | 2.1 | Q3 | 64.8 | 35.2 | 110/169 | 1.8 | Q3 | 2.0 | 0.4 | 0.45 | 118/327 | Q2 | 64.07 | 0.004 | 0.956 | 0.412 | Q3 | 329 | 88.2% | 3.4 | 6.9 | 290 | 14.6% | 2025-04-21 10:15:49 | 바로가기 |
| Open Medicine | DE GRUYTER POLAND SP Z O O | 2391-5463 | 2391-5463 | SCIE | MEDICINE, GENERAL & INTERNAL | 1,945 | 2.1 | Q3 | 64.8 | 35.2 | 110/169 | 2.1 | Q3 | 2.1 | 0.5 | 0.46 | 116/327 | Q2 | 64.68 | 0.002 | 0.480 | 0.402 | Q3 | 193 | 92.2% | 3.4 | 5.8 | 178 | 96.0% | 2025-04-21 10:15:52 | 바로가기 |
| SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE | TAYLOR & FRANCIS LTD | 0281-3432 | 1502-7724 | SCIE | MEDICINE, GENERAL & INTERNAL | 1,745 | 2.1 | Q3 | 64.8 | 35.2 | 110/169 | 2.5 | Q3 | 1.7 | 0.2 | 0.88 | 61/327 | Q1 | 81.50 | 0.002 | 0.329 | 0.635 | Q2 | 57 | 96.5% | 7.6 | 6.9 | 55 | 94.2% | 2025-04-21 10:15:52 | 바로가기 |
| CANCER CHEMOTHERAPY AND PHARMACOLOGY | SPRINGER | 0344-5704 | 1432-0843 | SCIE | ONCOLOGY | 10,905 | 3.0 | Q3 | 64.9 | 35.1 | 157/241 | 3.1 | Q3 | 2.9 | 0.7 | 0.70 | 144/318 | Q2 | 54.87 | 0.006 | 1.349 | 0.633 | Q4 | 115 | 92.2% | 8.9 | 7.5 | 106 | 24.8% | 2025-04-21 10:21:10 | 바로가기 |
| CATALYSIS LETTERS | SPRINGER | 1011-372X | 1572-879X | SCIE | CHEMISTRY, PHYSICAL | 13,557 | 2.8 | Q3 | 64.9 | 35.1 | 105/161 | 2.7 | Q3 | 2.7 | 0.5 | 0.38 | 130/172 | Q4 | 24.71 | 0.007 | 1.507 | 0.407 | Q3 | 374 | 99.5% | 8.3 | 6.2 | 372 | 5.2% | 2025-04-21 09:38:55 | 바로가기 |
| CHEMICAL PHYSICS LETTERS | ELSEVIER | 0009-2614 | 1873-4448 | SCIE | CHEMISTRY, PHYSICAL | 47,319 | 2.8 | Q3 | 64.9 | 35.1 | 105/161 | 2.3 | Q3 | 2.7 | 0.9 | 0.58 | 86/172 | Q2 | 50.29 | 0.014 | 3.002 | 0.365 | Q3 | 782 | 99.6% | 18.1 | 7.3 | 779 | 5.4% | 2025-04-21 09:38:49 | 바로가기 |
| Computational and Theoretical Chemistry | ELSEVIER | 2210-271X | 1872-7999 | SCIE | CHEMISTRY, PHYSICAL | 5,343 | 2.8 | Q3 | 64.9 | 35.1 | 105/161 | 2.0 | Q4 | 2.5 | 0.9 | 0.40 | 124/172 | Q3 | 28.20 | 0.004 | 0.778 | 0.289 | Q4 | 331 | 100.0% | 5.1 | 8.9 | 331 | 2.4% | 2025-04-21 09:38:58 | 바로가기 |
| CURRENT CANCER DRUG TARGETS | BENTHAM SCIENCE PUBL LTD | 1568-0096 | 1873-5576 | SCIE | ONCOLOGY | 3,540 | 3.0 | Q3 | 64.9 | 35.1 | 157/241 | 3.5 | Q3 | 3.0 | 0.7 | 0.45 | 221/318 | Q3 | 30.66 | 0.002 | 0.429 | 0.611 | Q4 | 68 | 42.6% | 9.0 | 6.6 | 29 | 1.0% | 2025-04-21 10:21:20 | 바로가기 |
| Hormones & Cancer | SPRINGER | 1868-8497 | 1868-8500 | SCIE | ONCOLOGY | 890 | 3.0 | Q3 | 64.9 | 35.1 | 157/241 | 3.2 | Q3 | 3.0 | N/A | 0.68 | 153/318 | Q2 | 52.04 | 0.001 | 0.143 | 0.656 | Q3 | 0 | N/A | 6.9 | N/A | 0 | 13.0% | 2025-04-21 10:21:31 | 바로가기 |
페이지 이동: